10th Indian Delegation to Dubai, Gitex & Expand North Star – World’s Largest Startup Investor Connect
HealthTech

Debt-laden PharmEasy plans INR 2,000-3,000 crore rights issue to repay loan

API Holdings, the parent company of debt-laden PharmEasy, has reportedly decided to raise funds through a rights issue. During an all-investor meeting held on Monday (July 17), the company approved a rights issue to raise INR 2,000 Cr to INR 3,000 Cr. The primary purpose of this fundraising exercise is to repay the loan taken from Goldman Sachs.

Manipal Group to Step in if Investors Don’t Fully Participate

As part of the rights issue, API Holdings has also approved a proposal from the Manipal Group. The Manipal Group has offered to invest any shortfall amount if all investors do not fully participate in the rights issue. The aim of this move is to ensure the success of the fundraising initiative.

PharmEasy Immediate Need for Funds

Earlier this month, PharmEasy had informed its board and investors about its plans to raise approximately INR 2,400 Cr through a rights issue. The startup is facing an urgent need for funds to pay off a Term B loan of INR 2,280 Cr ($285 Mn), for which it had pledged shares of its subsidiary, Thyrocare, as collateral.

Manipal Group’s Offer to Invest

As per the latest report, the Manipal Group’s family office has expressed its willingness to invest up to INR 1,300 Cr in the e-pharmacy startup. However, some investors at PharmEasy had reservations about selling shares to the Manipal Group at low valuations.

Post-Money Valuation and Previous Challenges

PharmEasy expects the post-money valuation to be in the range of INR 6,000 Cr to INR 7,000 Cr (approximately $730 Mn-$850 Mn) following this investment. This valuation marks a significant drop from its previous valuation of $2.8 Bn during its last fundraise.

PharmEasy has faced challenges recently, breaching its loan covenant terms with Goldman Sachs. The startup was expected to raise an equity round of around INR 1,000 Cr ($120 Mn) but failed to do so. This led to the need for raising high-cost debt to pay off a previous debt used to acquire Thyrocare. Additionally, the company’s plans for a substantial INR 6,250 Cr IPO, filed in November 2021, were unsuccessful amid a severe market downturn.

Also Read The Latest News:
Cashfree Payments launches ‘BNPL Plus’ to enhance customer payment options
OneCard and WintWealth apply for NBFC licences

by PNN

Bengaluru (Karnataka) [India], November 8: Healthy Hubba, India’s first Children’s Health Festival & Childhood Obesity Conference, will be held on Saturday, November 15, 2025 at the Indian Institute of Science (IISc), Bengaluru. The event is co-presented by Solutionec and Hlty Beings, with support from Rotary Bengaluru Platinum City (District 3192) and quiz partner Quizarre. The festival has been planned against the backdrop of growing concern over childhood obesity and lifestyle-related health problems in India. The programme focuses… Source link

by PNN

ACTIZEET: The Himalayan Promise: Purity, Potency, Purpose   Kolkata (West Bengal) [India], November 7: ACTIZEET, India’s trusted name in pure herbal wellness, proudly marks its 29th anniversary this year. Established in 1996, ACTIZEET began as a small Himalayan initiative to bring authentic Shilajit to the world, and today it stands as a legacy brand that has redefined purity, potency, and purpose in the Indian wellness landscape. From a Modest Beginning to a National Legacy What started in the serene Drass Valley of Ladakh under the vision… Source link

by PNN

Mumbai (Maharashtra) [India], November 5: Low premiums look pleasing when comparing health insurance plans, yet the price on the screen can hide expenses that appear only when a claim is made. The real cost often sits in the policy wording and in how efficiently claims are paid. This blog will cover an easy way to read the claim settlement ratio, how “cheap” options can cost more at claim time, and a checklist for sensible comparison. What Claim Settlement Ratio Really Tells You The claim settlement ratio shows the share of claims an… Source link